Source:http://linkedlifedata.com/resource/pubmed/id/17437111
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2007-6-22
|
pubmed:abstractText |
AMD3100, a competitive antagonist of CXCR-4, disrupts the binding of its ligand, stromal cell-derived factor-1 (SDF-1), and facilitates stem cell mobilisation in patients with haematological malignancies. This study investigated the differential kinetics of CXCR-4 and adhesion molecule expression and their impact on stem cell yield during mobilisation with granulocyte-colony stimulating factor (G-CSF) (days 1-4) followed by AMD3100 in 10 patients with multiple myeloma. A four-colour flow cytometry-based determination of CXCR-4, VLA-4, L-selectin, PECAM, LFA-1 and CD44 expression on CD34+ cells and measurement of SDF-1 concentration were performed at different time points. After G-CSF alone, CXCR-4 expression on patients' blood and marrow CD34+ cells was significantly lower than in the healthy controls (p < 0.001), but allowed no prediction of stem cell yield. Except in the single poorly mobilising patient, AMD3100 led to a further significant decrease of CXCR4 (p = 0.001), which inversely correlated with the CD34+ counts in the blood (p = 0.005). SDF-1 level in patients' marrow was positively correlated with CXCR-4 expression on CD34+ cells (p = 0.011). It is interesting to note that the expression of adhesion molecules remained unaffected by AMD3100 administration. Further studies will define the possible prognostic role of AMD3100 mediated changes in CXCR-4 expression for the prediction of stem cell yield attainable with this new mobilisation regimen.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cell Adhesion Molecules,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating...,
http://linkedlifedata.com/resource/pubmed/chemical/Heterocyclic Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/JM 3100,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CXCR4
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0939-5555
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
86
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
569-73
|
pubmed:meshHeading |
pubmed-meshheading:17437111-Cell Adhesion Molecules,
pubmed-meshheading:17437111-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:17437111-Hematopoietic Stem Cell Mobilization,
pubmed-meshheading:17437111-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:17437111-Heterocyclic Compounds,
pubmed-meshheading:17437111-Humans,
pubmed-meshheading:17437111-Kinetics,
pubmed-meshheading:17437111-Multiple Myeloma,
pubmed-meshheading:17437111-Receptors, CXCR4,
pubmed-meshheading:17437111-Transplantation, Autologous
|
pubmed:year |
2007
|
pubmed:articleTitle |
Kinetics of CXCR-4 and adhesion molecule expression during autologous stem cell mobilisation with G-CSF plus AMD3100 in patients with multiple myeloma.
|
pubmed:affiliation |
Medical Clinic and Polyclinic I, University Hospital of the Technical University of Dresden, House 66, Fetscherstrasse 74, 01307 Dresden, Germany.
|
pubmed:publicationType |
Journal Article
|